116 reports of this reaction
2.0% of all SILODOSIN reports
#9 most reported adverse reaction
ANAEMIA is the #9 most commonly reported adverse reaction for SILODOSIN, manufactured by Ajanta Pharma USA Inc.. There are 116 FDA adverse event reports linking SILODOSIN to ANAEMIA. This represents approximately 2.0% of all 5,716 adverse event reports for this drug.
Patients taking SILODOSIN who experience anaemia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ANAEMIA is a less commonly reported adverse event for SILODOSIN, but still significant enough to appear in the safety profile.
In addition to anaemia, the following adverse reactions have been reported for SILODOSIN:
The following drugs have also been linked to anaemia in FDA adverse event reports:
ANAEMIA has been reported as an adverse event in 116 FDA reports for SILODOSIN. This does not prove causation, but indicates an association observed in post-market surveillance data.
ANAEMIA accounts for approximately 2.0% of all adverse event reports for SILODOSIN, making it a notable side effect.
If you experience anaemia while taking SILODOSIN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.